Nature Biomedical Engineering

Nature Biomedical Engineering is a monthly, online-only journal published by Nature Portfolio, launched in January 2017, covering applied biomedicine and health technology, with a 2025 Journal Impact Factor of 26.3《自然·生物医学工程》是（Nature Portfolio）出版的月度纯在线期刊，2017 年 1 月创刊，涵盖应用生物医学与健康技术，2025 年影响因子为 26.3。

Scope

• It publishes original research, reviews and commentary in applied biomedicine and health technology该刊刊载应用生物医学与健康技术领域的原创研究、综述与评论。^[1]
• Its scope includes tissue engineering, biomedical imaging, regenerative medicine and medical devices其范围涵盖组织工程、生物医学成像、再生医学与医疗器械。
• Its audience includes life scientists developing experimental or computational methods to understand human physiology其读者包括研发实验或计算方法以理解人体生理的生命科学家。
• It also reaches biomedical researchers and engineers designing or optimising therapies, assays, devices or procedures其读者还包括设计或优化疗法、检测、器械或操作流程的生物医学研究者与工程师。
• It serves clinicians who use research outputs to assess patient health or deliver therapy该刊亦服务于借助研究成果评估患者健康或实施治疗的临床医生。
• The journal applies engineering and physical-science approaches to problems in medicine and biology该刊将工程学与物理科学的方法应用于医学与生物学问题。
• It is an online-only monthly journal and has no print edition该刊为月度纯在线期刊，不出版印刷版。

History

• The journal was launched in January 2017 as a Nature Portfolio title dedicated to biomedical engineering该刊于 2017 年 1 月创刊，为（Nature Portfolio）专注生物医学工程的期刊。
• It was established by Pep Pamies, who had spent more than five years as an editor at Nature Materials该刊由 Pep Pamies 创办，他此前在（Nature Materials）任编辑逾五年。
• It has been published online only and monthly since its launch该刊自创刊起即按月、仅在线出版。
• It forms part of the Nature Portfolio of journals published by Springer Nature该刊隶属（Springer Nature）旗下（Nature Portfolio）期刊系列。
• It is a hybrid journal, with subscription content and an open-access option该刊为混合期刊，既有订阅内容，也提供开放获取选项。
• Its 2025 Journal Impact Factor is 26.3, ranking second among 130 biomedical engineering journals其 2025 年影响因子为 26.3，在 130 种生物医学工程期刊中排名第二。

Editors

• The Editor-in-Chief is Pep Pamies, who has led the journal since its launch in 2017现任主编为 Pep Pamies，自 2017 年创刊起执掌该刊。
• Before joining the journal he worked as an editor at Nature Materials for more than five years在加入该刊之前，他在（Nature Materials）任编辑逾五年。
• At Nature Materials he handled manuscripts and commissioned articles on tissue engineering, medical imaging and biomaterials在（Nature Materials）期间，他负责组织工程、医学成像与生物材料方向的稿件处理与约稿。
• The editorial team works with an editorial advisory board of distinguished clinicians and medical engineers编辑团队与由杰出临床医生与医学工程师组成的编辑顾问委员会协同工作。
• All editorial decisions are the responsibility of the editors, who are advised by that board所有编辑决定由编辑负责，该委员会向其提供建议。
• Manuscripts undergo peer review before publication稿件在发表前均经同行评审。